Cancer cells rely on extensive dNTP supply to sustain continuous growth; overexpression of RRM2 is closely related to tumorigenesis and disease progression in many cancer types, leading to its recognition as an effective target of anticancer therapies [23, 24]. This evidence concerns the gene RRM2 and cancer.